Kenneth C. Frazier made one open market purchase of Eikon Therapeutics ($EIKN) shares in the last year, totaling nearly $2 million. His latest buy occurred on February 4, 2026. Among 4,983 insiders, his activity ranks 320th by purchase value, surpassing the average of $1.46 million across 3.29 transactions per insider. Frazier reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Eikon Therapeutics, Inc. | $EIKN | FRAZIER KENNETH C | Not found | A | Stock Option (Right to Buy) | 25873 | $0.00 | 25,873.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Eikon Therapeutics, Inc. | $EIKN | FRAZIER KENNETH C | Not found | P | Common Stock | 111111 | $18.00 | 111,111.0000 | 0 | 9999.99% | 0.00% |